| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |